Training program for childhood blood cancers

Childhood Hematological Malignancies Training Program

NIH-funded research St. Jude Children's Research Hospital · NIH-10849301

This program is all about helping new scientists learn how to create better treatments for kids with blood cancers by using the latest genetic discoveries, so they can improve how these cancers are diagnosed and treated.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-10849301 on NIH RePORTER

What this research studies

This program focuses on training new scientists to understand and develop better treatments for childhood hematological malignancies, which are the most common type of cancer in children. It aims to translate genetic discoveries into practical insights that can improve diagnosis and therapy for these cancers. The program provides hands-on experience in genomic analysis and experimental modeling, preparing trainees to become leaders in this critical field of pediatric oncology.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research are children diagnosed with hematological malignancies and their families seeking advanced treatment options.

Not a fit: Patients with non-hematological cancers or those who do not have access to the training program may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and outcomes for children diagnosed with hematological malignancies.

How similar studies have performed: Other training programs focused on pediatric cancers have shown success in advancing treatment and understanding of these diseases, making this approach promising.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Hematologic CancerHematopoietic Cancer
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.